Breast Cancer
Advancing breast cancer and lymphedema care with the Symani® Surgical System
Patients with breast cancer face significant reconstructive and rehabilitative challenges following their treatment.
The Symani Surgical System supports comprehensive breast cancer care by enabling precise and accurate microsurgery and supermicrosurgery procedures to help restore function and improve quality of life.
2
M+
people are diagnosed with breast cancer every year worldwide1,2
20
%
of patients who undergo mastectomy choose an autologous reconstruction utilizing their own tissue, a method with significant benefits3
30
%
of patients with breast cancer develop lymphedema following their treatment4
Advantages of the Symani Surgical System in Breast Cancer Treatment
Access reconstructive surgery with innovative robotic technology
With the Symani Surgical System, patients with breast cancer can more easily access autologous reconstruction, an option with significant benefits over implant-based reconstruction including lower failure rates, up to 23% lower readmission rates, and higher patient satisfaction3,4.
Combining breast reconstruction with lymphatic repair
Hospitals offering, or looking to offer, surgical options for lymphedema can also help prevent or treat symptoms in patients with breast cancer following their treatment.
Precision at the micro level
Our proprietary NanoWrist® instruments feature the world’s smallest surgical robotic wrist, designed to replicate the natural movements of the human hand at the micro level with seven degrees of freedom. With tremor filtration and up to 20x motion scaling, surgeons gain unmatched precision, which has the potential to enhance vessel patency, minimize trauma, and reduce the need for costly re-interventions—transforming outcomes in complex procedures.
Expert Testimonials and Patient Perspectives
Gain firsthand insights from surgeons and patients on the impact of the Symani Surgical System in breast cancer care.
Robotic Precision, Proven Results: The Symani® Clinical Advantage
A growing body of clinical evidence demonstrates the positive impact of the Symani Surgical System in reconstructive and microsurgery.
96.8
%
free flap survival rate
Robotic-assisted reconstruction matches manual outcomes at discharge5
0
%
occlusive thrombus with robotics
Robotics may reduce thrombus risk in microvascular reconstruction6
4
trials to reach proficiency
Surgeons achieve rapid learning curve in robotic microsurgery7
Breast Cancer Resources
Explore our other Clinical Applications
Lymphedema
Lymphedema, the build-up of lymphatic fluid resulting in swelling and discomfort, affects over 250 million people worldwide.* Surgical treatment options may improve the symptoms and overall quality of life for these patients, but access to these treatments is limited. This is mainly due to procedural complexity associated with the size of lymphatic vessels. With 7-20x motion scaling and tremor filtration, the Symani Surgical System is designed to enable supermicrosurgical procedures such as lymphovenous anastomosis or bypass (LVA/LVB).
Head & Neck Cancer
The incidence of head & neck cancers is on the rise and increasing the need for reconstructive procedures that utilize microsurgical techniques. Reconstruction of the head and neck following tumor resection or trauma can help restore function and improve quality of life for patients. With Symani, surgeons can perform these challenging and complex procedures with a high degree of precision and control in an optimized work environment.
Trauma
Trauma refers to any altering injury sustained through accident or impact like burns, laceration, crush, nerve damage and fractures. Where tissue is lost due to trauma or infection, it may be necessary to perform a reconstructive procedure using transferred tissue or to perform a replantation of an amputated body part with the goal of restoring circulation and sensation, and where possible, function. Symani allows surgeons to confidently perform these procedures with a high degree of precision and accuracy.
Interested in Reimbursement?
Explore how Symani procedures may be eligible for reimbursement and what that means for your practice
CITATIONS
- World Health Organization. (n.d.). Retrieved from https://www.who.int/news-room/fact-sheets/detail/breast-cancer
- Sawyer JD, et al. Autologous Breast Reconstruction is Associated with Lower 90-day Readmission Rates. Plastic and Reconstructive Surgery – Global Open 10(2):p e4112, February 2022.
- Broyles JM, et al. (2022). Implant-based versus Autologous Reconstruction after Mastectomy for Breast Cancer: A Systematic Review and Meta-analysis. Plastic and reconstructive surgery. Global open, 10(3), e4180.
- Zou L, et al. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study. Breast Cancer 25, 309–314 (2018).
- PRIMO PMCF clinical study. Data on file.
- SAFE Microsurgery GLP preclinical study. Data on file.
- Cho J, et al. Further Validating the Robotic Microsurgery Platform through Preclinical Studies on Rat Femoral Artery and Vein. J Reconstr Microsurg. Published online January 17, 2025. doi:10.1055/a-2460-4940
DISCLAIMER
MMI does not provide medical advice. Only your doctor can determine whether procedures with the Symani Surgical System are appropriate for you.
